L

Lepu Medical Technology Beijing Co Ltd
SZSE:300003

Watchlist Manager
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Watchlist
Price: 12.58 CNY 4.66% Market Closed
Market Cap: 23.7B CNY
Have any thoughts about
Lepu Medical Technology Beijing Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one Lepu Medical Technology Beijing Co Ltd stock under the Base Case scenario is 18.6 CNY. Compared to the current market price of 12.58 CNY, Lepu Medical Technology Beijing Co Ltd is Undervalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
18.6 CNY
Undervaluation 32%
Relative Value
Price
L
Worst Case
Base Case
Best Case

Valuation Multiples

3.3
P/S
P/S
Price to Sales
3.3
vs History
88
vs Industry
37
Median 3Y
3.7
Median 5Y
4.1
Industry
2.4
Forward
3.5
More Details
23.8
P/E
P/E
Price to Earnings
23.8
vs History
60
vs Industry
26
Median 3Y
22.1
Median 5Y
24.1
Industry
22.9
Forward
21.7
More Details
23.5
P/OCF
P/OCF
Price to OCF
23.5
vs History
39
vs Industry
20
Median 3Y
18.5
Median 5Y
20.2
Industry
14.5
More Details
20.2
P/FCFE
P/FCFE
Price to FCFE
20.2
vs History
92
vs Industry
18
Median 3Y
38.4
Median 5Y
39.4
Industry
20.5
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
95
vs Industry
50
Median 3Y
2.7
Median 5Y
3.1
Industry
2.2
More Details
3.6
EV/S
EV/S
Enterprise Value to Sales
3.6
vs History
84
vs Industry
34
Median 3Y
3.7
Median 5Y
4
Industry
2.4
Forward
3.7
More Details
5.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.8
vs History
84
vs Industry
41
Median 3Y
6
Median 5Y
6.5
Industry
5
More Details
19.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.4
vs History
44
vs Industry
20
Median 3Y
15.5
Median 5Y
18.3
Industry
12.6
Forward
13.3
More Details
19.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.4
vs History
44
vs Industry
27
Median 3Y
15.5
Median 5Y
18.3
Industry
17.1
Forward
12
More Details
25.2
EV/OCF
EV/OCF
Enterprise Value to OCF
25.2
vs History
36
vs Industry
21
Median 3Y
18.3
Median 5Y
20.2
Industry
14.1
More Details
83.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
83.8
vs History
9
vs Industry
9
Median 3Y
31.6
Median 5Y
34.7
Industry
17.7
More Details
1.2
EV/IC
EV/IC
Enterprise Value to IC
1.2
vs History
95
vs Industry
51
Median 3Y
2.1
Median 5Y
2.4
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Lepu Medical Technology Beijing Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
23.7B CNY 3.3 23.8 19.4 19.4
US
Abbott Laboratories
NYSE:ABT
204.7B USD 5 35.5 20.7 30.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.7B USD 23 80.6 68.7 85.3
US
Stryker Corp
NYSE:SYK
139.9B USD 6.4 39 25.3 30.7
US
Boston Scientific Corp
NYSE:BSX
124.8B USD 7.8 69.6 32 45.8
IE
Medtronic PLC
NYSE:MDT
114.5B USD 3.5 29.2 15.2 21.7
US
Becton Dickinson and Co
NYSE:BDX
67.7B USD 3.4 47.9 15.4 27.3
DE
Siemens Healthineers AG
XETRA:SHL
53.8B EUR 2.4 28.9 16.6 24.2
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
338.5B CNY 9.1 26.6 23.5 23.5
US
Edwards Lifesciences Corp
NYSE:EW
40B USD 7.1 9.6 22.2 24.3
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.7B USD 2 23.7 14.7 18.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 194,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.